Page 2482 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 151 Hematologic Changes in Pregnancy 2214.e5

214. Petri M, Rheinschmidt M, Whiting-O’Keefe P, et al: The frequency of 219. Branch DW, Scott JR, Kochenour NK, et al: Obstetric complications
lupus anticoagulant in systemic lupus erythematosus: a study of sixty associated with the lupus anticoagulant. N Engl J Med 313:1322, 1985.
consecutive patients by activated partial thromboplastin time, Russell 220. Yasuda M, Takakuwa K, Tokunaga A, et al: Prospective studies of the
viper venom time, and anticardiolipin antibody level. Ann Intern Med association between anticardiolipin antibody and outcome of preg-
106:524, 1987. nancy. Obstet Gynecol 86:555, 1995.
215. Higasa S, Matsuda T, Ueda M, et al: Activation of normal platelet 221. Branch DW, Silver RM, Blackwell JL, et al: Outcome of treated preg-
function by adding antiphospholipid antibody positive IgG fraction. nancies in women with antiphospholipid syndrome: an update of the
Thromb Haemost 69:594a, 1993. Utah experience. Obstet Gynecol 80:614, 1992.
216. Lindsey NJ, Dawson RA, Henderson FI, et al: Stimulation of von 222. Kutteh WH: Antiphospholipid antibodies and reproduction. J Reprod
Willebrand factor antigen release by immunoglobulin from thrombosis Immunol 35:151, 1997.
prone patients with systemic lupus erythematosus and the antiphospho- 223. Franchini M, Veneri D: The antiphospholipid syndrome. Hematology
lipid syndrome. Br J Rheumatol 32:123, 1993. 10:265, 2005.
217. Rand JH, Wu XX, Andree HA, et al: Pregnancy loss in the antiphos- 224. Derksen RH, Out HJ, Blokziji L, et al: Detection of lupus anticoagu-
pholipid antibody syndrome—a possible thrombogenic mechanism. lant in pregnancy (letter). Clin Exp Rheumatol 10:323, 1992.
N Engl J Med 337:154, 1997.
218. Oshiro BT, Silver RM, Scott JR, et al: Antiphospholipid antibodies and
fetal death. Obstet Gynecol 87:489, 1996.